Scarica l'app Stockscreener
8.68
4.51%
-0.41
Pre-mercato:
8.75
0.07
+0.81%
Zenas Biopharma Inc Borsa (ZBIO) Ultime notizie
Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and BigBear and Encourages Investors to Contact the Firm - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and BigBear and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Zenas BioPharma Investors: Cohen Milstein Highlights June - GlobeNewswire
Shareholders of Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 ... - Eagle-Tribune
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
Investors in Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your RightsZBIO - ACCESS Newswire
Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025ZBIO - PR Newswire
Shareholders That Lost Money on Zenas BioPharma, Inc. (ZBIO) Should Contact Levi & Korsinsky About Pending Class ActionZBIO - ACCESS Newswire
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Lawsuit Filed by The Rosen Law Firm - PR Newswire
Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 16, 2025ZBIO - ACCESS Newswire
Zenas BioPharma, Inc. Sued for Securities Law Violations – - GlobeNewswire
Zenas BioPharma, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before June 16, 2025 to Discuss Your Rights – ZBIO - TradingView
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Zenas BioPharma, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationZBIO - ACCESS Newswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas BioPharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Zenas BioPharma, Inc.(ZBIO) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
2025-05-10 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma | NDAQ:ZBIO | Press Release - Stockhouse
Cohen Milstein Continues Lead Plaintiff Search for Zenas - GlobeNewswire
Shareholders of Zenas BioPharma, Inc. Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your RightsZBIO - ACCESS Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - ACCESS Newswire
Shareholders Who Lost Money on Zenas BioPharma, Inc. (ZBIO) Should Contact Levi & Korsinsky about Pending Class ActionZBIO - ACCESS Newswire
Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 – ZBIO - TradingView
ZBIO Shareholders Have Opportunity to Lead Zenas BioPharma, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - PR Newswire
ZBIO Stock Notice: Zenas BioPharma, Inc. Stockholders are - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Zenas BioPharma, Inc. (ZBIO) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Shareholders that lost money on Zenas BioPharma, Inc.(ZBIO) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
ZBIO Stock Notice: Zenas BioPharma, Inc. Stockholders are Encoura - NatLawReview.com
ZBIO Stock Notice: Zenas BioPharma, Inc. Stockholders are Encouraged to Contact Shareholder ... - Bluefield Daily Telegraph
Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Zenas ... - Bluefield Daily Telegraph
Bullish Zenas BioPharma Insiders Loaded Up On US$2.11m Of Stock - simplywall.st
The Gross Law Firm Notifies Shareholders of Zenas BioPharma, Inc.(ZBIO) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Shareholders of Zenas BioPharma, Inc. Should Contact Levi & Kors - GuruFocus
Cohen Milstein Seeks Investors to Lead Suit to Hold Zenas BioPharma (ZBIO) Accountable for IPO-Related Fraud - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors - GlobeNewswire
Zenas BioPharma, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your RightsZBIO - ACCESS Newswire
The Gross Law Firm Notifies Shareholders of Zenas BioPharma, Inc - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
Robbins LLP Reminds ZBIO Stockholders with Large Losses to Contact the Law Firm for Information - Bluefield Daily Telegraph
Robbins LLP Reminds ZBIO Stockholders with Large Losses to - GlobeNewswire
Robbins LLP Reminds ZBIO Stockholders with Large Losses to Contact the Law Firm for Information on Leading the Zenas BioPharma, Inc. Class Action - TradingView
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):